Aimmune Therap (AIMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2015 | 03-2015 | 12-2014 | 09-2014 | 06-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 58,502 | N/A | N/A | N/A | N/A |
| TOTAL | $60,607 | $N/A | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 1,253 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 214 | 0 | 0 | 0 | 0 |
| TOTAL | $1,467 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $62,074 | $N/A | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 309 | 0 | 0 | 0 | 0 |
| Accrued Expenses | 2,796 | N/A | N/A | N/A | N/A |
| Other current liabilities | 222 | N/A | N/A | N/A | N/A |
| TOTAL | $3,327 | $N/A | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 784 | 0 | 0 | 0 | 0 |
| TOTAL | $784 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $4,111 | $N/A | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 42,249 | N/A | N/A | N/A | N/A |
| Retained earnings | -28,334 | N/A | N/A | N/A | N/A |
| Other shareholders' equity | 83,833 | 0 | 0 | 0 | 0 |
| TOTAL | $57,963 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $62,074 | $0 | $0 | $0 | $0 |